Gene expression profiles associated with chemotherapy in acute lymphoid leukemia of childhood

• Grant number: 01/13206-9
• Support Opportunities: Genome Research Grants
• Start date: May 01, 2002
• End date: December 31, 2004
• Field of knowledge: Health Sciences - Medicine - Maternal and Child Health
• Principal Investigator: Luiz Gonzaga Tone
• Grantee: Luiz Gonzaga Tone
• Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Scientific publications

(5)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

BRANDALISE, SILVIA R.; PINHEIRO, VITORIA R.; AGUIAR, SIMONE S.; MATSUDA, EDUARDO I.; OTUBO, ROSEMARY; YUNES, JOSE A.; PEREIRA, WALDIR V.; CARVALHO, ENY G.; CRISTOFANI, LILIAN M.; SOUZA, MARCELO S.; et al. Benefits of the Intermittent Use of 6-Mercaptopurine and Methotrexate in Maintenance Treatment for Low-Risk Acute Lymphoblastic Leukemia in Children: Randomized Trial From the Brazilian Childhood Cooperative Group Protocol ALL-99. Journal of Clinical Oncology, v. 28, n. 11, p. 1911-1918, APR 10 2010. (01/13206-9)

SCRIDELI, CARLOS ALBERTO; ABDALA CORTEZ, MARIA ANGELICA; YUNES, JOSE ANDRES; DE PAULA QUEIROZ, ROSANE GOMES; VALERA, ELVIS TERCI; DA MATA, JULIANA FRANCA; CAMINADA TELEDO, SILVIA REGINA; PAVONI-FERREIRA, PRISCILA; DE MARTINO LEE, MARIA LUCIA; PETRILLI, ANTONIO SERGIO; et al. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor. Leukemia Research, v. 34, n. 1, p. 32-37, 2010. (01/13206-9)

CORTEZ, MARIA A. A.; SCRIDELI, CARLOS A.; YUNES, JOSE A.; VALERA, ELVIS T.; TOLEDO, SILVIA R. C.; PAVONI-FERREIRA, PATRICIA C. B.; LEE, MARIA L. M.; PETRILLI, ANTONIO S.; BRANDALISE, SILVIA R.; TONE, LUIZ G.. mRNA Expression Profile of Multidrug Resistance Genes in Childhood Acute Lymphoblastic Leukemia. Low Expression Levels Associated With a Higher Risk of Toxic Death. PEDIATRIC BLOOD & CANCER, v. 53, n. 6, p. 996-1004, DEC 1 2009. (01/13206-9)

SILVEIRA, VANESSA S.; SCRIDELI, CARLOS ALBERTO; MORENO, DANIEL A.; YUNES, JOSE ANDRES; QUEIROZ, ROSANE G. P.; TOLEDO, SILVIA C.; LEE, MARIA LUCIA M.; PETRILLI, ANTONIO S.; BRANDALISE, SILVIA R.; TONE, LUIZ GONZAGA. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia. Leukemia & Lymphoma, v. 54, n. 2, p. 310-314, FEB 2013. (01/13206-9)

MORENO, DANIEL ANTUNES; SCRIDELI, CARLOS ALBERTO; ABDALA CORTEZ, MARIA ANGELICA; QUEIROZ, ROSANE DE PAULA; VALERA, ELVIS TERCI; SILVEIRA, VANESSA DA SILVA; YUNES, JOSE ANDRES; BRANDALISE, SILVIA REGINA; TONE, LUIZ GONZAGA. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. British Journal of Haematology, v. 150, n. 6, p. 665-673, SEP 2010. (01/13206-9)